These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10792365)

  • 21. CD40 stimulation provides an IFN-gamma-independent and IL-4-dependent differentiation signal directly to human B cells for IgE production.
    Zhang K; Clark EA; Saxon A
    J Immunol; 1991 Mar; 146(6):1836-42. PubMed ID: 1706382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitors of the p38 mitogen-activated kinase modulate IL-4 induction of low affinity IgE receptor (CD23) in human monocytes.
    Marshall LA; Hansbury MJ; Bolognese BJ; Gum RJ; Young PR; Mayer RJ
    J Immunol; 1998 Dec; 161(11):6005-13. PubMed ID: 9834082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of IL-2 and IL-4 on the IgE synthesis and the IgE-binding factor (sCD23) production by human lymphocytes in vitro.
    Knöller I; Bujanowski-Weber J; Brings B; König W
    Immunology; 1989 Mar; 66(3):368-75. PubMed ID: 2522907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells.
    Frémeaux-Bacchi V; Fischer E; Lecoanet-Henchoz S; Mani JC; Bonnefoy JY; Kazatchkine MD
    Int Immunol; 1998 Oct; 10(10):1459-66. PubMed ID: 9796912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stimulation of human IgE production by a subset of anti-CD21 monoclonal antibodies: requirement of a co-signal to modulate epsilon transcripts.
    Henchoz S; Gauchat JF; Aubry JP; Graber P; Pochon S; Bonnefoy JY
    Immunology; 1994 Feb; 81(2):285-90. PubMed ID: 7512529
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of cell-bound and soluble CD23, spontaneous and ongoing IgE synthesis of human peripheral blood mononuclear cells by soluble IL-4 receptors and the partial antagonistic IL-4 mutant protein IL-4 (Y124D).
    König B; Fischer A; König W
    Immunology; 1995 Aug; 85(4):604-10. PubMed ID: 7558156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human recombinant interleukin 4 induces normal B cells to produce soluble CD23/IgE-binding factor analogous to that spontaneously released by lymphoblastoid B cell lines.
    Bonnefoy JY; Defrance T; Peronne C; Menetrier C; Rousset F; Pène J; De Vries JE; Banchereau J
    Eur J Immunol; 1988 Jan; 18(1):117-22. PubMed ID: 2831064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-4 and IgE-anti-IgE modulation of 15(S)-hydroxyeicosatetraenoic acid release by mononuclear phagocytes.
    Profita M; Vignola AM; Mirabella A; Siena L; Sala A; Gjomarkaj M; Bousquet J; Bonsignore G
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):159-64. PubMed ID: 9893200
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of IL-4-induced human IgE production in vitro by IFN-gamma and IL-5: the role of soluble CD23 (s-CD23).
    Pène J; Chrétien I; Rousset F; Brière F; Bonnefoy JY; de Vries JE
    J Cell Biochem; 1989 Mar; 39(3):253-64. PubMed ID: 2496134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation.
    Luo HY; Hofstetter H; Banchereau J; Delespesse G
    J Immunol; 1991 Apr; 146(7):2122-9. PubMed ID: 1826018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total and birch pollen-specific human IgE in mice with severe combined immunodeficiency transplanted with human peripheral blood lymphocytes: donor dependence, seasonal variation and in vivo half-life.
    Steinsvik TE; Aaberge IS; Gaarder PI; Bjønness U; Løvik M
    Int Arch Allergy Immunol; 1997 Feb; 112(2):175-83. PubMed ID: 9030099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CTLA4Fcε, a novel soluble fusion protein that binds B7 molecules and the IgE receptors, and reduces human in vitro soluble CD23 production and lymphocyte proliferation.
    Perez-Witzke D; Miranda-García MA; Suárez N; Becerra R; Duque K; Porras V; Fuenmayor J; Montano RF
    Immunology; 2016 May; 148(1):40-55. PubMed ID: 26801967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory role of cytokines and CD23 in the human IgE antibody synthesis.
    Pène J
    Int Arch Allergy Appl Immunol; 1989; 90 Suppl 1():32-40. PubMed ID: 2533178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ligation of CD23 triggers cyclic AMP generation in human B lymphocytes.
    Kolb JP; Abadie A; Paul-Eugene N; Capron M; Sarfati M; Dugas B; Delespesse G
    J Immunol; 1993 Jun; 150(11):4798-809. PubMed ID: 8388420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased production of soluble CD23 in rheumatoid arthritis, and its regulation by interleukin-4.
    Chomarat P; Briolay J; Banchereau J; Miossec P
    Arthritis Rheum; 1993 Feb; 36(2):234-42. PubMed ID: 8431213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibitors of protein tyrosine kinases and protein tyrosine phosphatases suppress IL-4-induced CD23 expression and release by human B lymphocytes.
    Kolb JP; Abadie A
    Eur Cytokine Netw; 1993; 4(6):429-38. PubMed ID: 8186375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Native and recombinant soluble CD23 fragments with IgE suppressive activity.
    Sarfati M; Bettler B; Letellier M; Fournier S; Rubio-Trujillo M; Hofstetter H; Delespesse G
    Immunology; 1992 Aug; 76(4):662-7. PubMed ID: 1398755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-9 potentiates the interleukin-4-induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes.
    Dugas B; Renauld JC; Pène J; Bonnefoy JY; Peti-Frère C; Braquet P; Bousquet J; Van Snick J; Mencia-Huerta JM
    Eur J Immunol; 1993 Jul; 23(7):1687-92. PubMed ID: 7686859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukotriene B4 enhances IL-4-induced IgE production from normal human lymphocytes.
    Yamaoka KA; Dugas B; Paul-Eugene N; Mencia-Huerta JM; Braquet P; Kolb JP
    Cell Immunol; 1994 Jun; 156(1):124-34. PubMed ID: 8200030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD23 shedding: requirements for substrate recognition and inhibition by dipeptide hydroxamic acids.
    Mayer RJ; Flamberg PL; Katchur SR; Bolognese BJ; Smith DG; Marolewski AE; Marshall LA; Faller A
    Inflamm Res; 2002 Feb; 51(2):85-90. PubMed ID: 11926319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.